Connect with us

Hi, what are you looking for?

Smart Investment StepsSmart Investment Steps

Editor's Pick

Placement Fully Subscribed

C29 Metals Limited (“C29” or the “Company”) is pleased to announce that it has received firm commitments from sophisticated and professional investors to raise $2,450,000 (before costs) through a placement of a total of 34,507,042 fully paid ordinary shares in the capital of the Company (Placement Shares) at an issue price of $0.071 each (Placement). The Placement saw strong support with demand significantly exceeding shares offered under the Placement.

HIGHLIGHTS

C29 has received firm commitments to raise $2.45m (before costs), which will be completed under the Company’s current Listing Rule 7.1 and 7.1(a) placement capacity.C29 Metals receives official notification all regulatory requirements met for the issue of drill permits

20,952,179 Placement Shares will be issued pursuant to the Company’s placement capacity under Listing Rule 7.1 and 13,554,863 Placement Shares will be issued pursuant to the Company’s placement capacity under Listing Rule 7.1A.

The issue price of $0.071 represents a 0% discount to the last trading price of $0.071 on 15 October 2024 and a premium of 3% to the 15-day volume weighted average price of $0.069.

Funds from the Placement will be directed towards exploration activities at the Company’s Ulytau Uranium Project and working capital.

The Company has engaged ARQ Capital Pty Ltd (Lead Manager) to manage the Placement. The Lead Manager (or its nominees) will receive a capital raising fee of 6% on the amount raised under the Placement, a management fee of $15,000 and 2,500,000 options with an exercise price of $0.115 expiring 12 December 2025 (Broker Options), the issue of the Broker Options is subject to shareholder approval at the Company’s upcoming AGM.

The Company has approved the issue of 4,000,000 Director Incentive Options (Director Options) to be issued to the Director (or their nominee), the issue of the Director Options is subject to shareholder approval at the Company’s upcoming AGM. The Director Options have an exercise price of $0.110 expiring three years from date of issue. The allocation of the Director Options is as follows, Mr Shannon Green to be issued 2,000,000 Director Options, Mr Jamie Myers to be issued 1,500,000 Director Options and Mr David Lees to be issued with 500,000 Director Options.

Click here for the full ASX Release

This post appeared first on investingnews.com

Enter Your Information Below To Receive Latest News and Articles




    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Fewer than 25 minutes into Donald Trump’s remarks, Melissa Prescott walked out. She arrived at the Linda Ronstadt Music Hall at 8:30 a.m. on...

    Latest News

    Former president Barack Obama will campaign for Vice President Kamala Harris in the month leading up to Election Day, kicking off his efforts with...

    Stock

    It’s time for a wellness check at CVS Health. Shares of the company are down more than 20% this year as it grapples with higher-than-expected medical...

    Investing

    As the U.S. mulls over a plan to withdraw troops from Iraq, its Kurdish allies have a message: Don’t forget us.  ‘This is not...

    Disclaimer: smartinvestmentsteps.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 smartinvestmentsteps.com